Global $8.74 Billion Interferons (IFN Alpha, Beta, Gamma) Markets, 2015-2020, 2020-2025F, 2030F
May 28, 2021 04:53 ET
|
Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Interferons Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. Major...
BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003
March 11, 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 11, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), today announced that its wholly-owned subsidiary, Altum...
Global Autoimmune Disease Therapeutics Market (2021 to 2025) - Size & Forecast with Impact Analysis of COVID-19
February 23, 2021 08:43 ET
|
Research and Markets
Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to...
BetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon Formulation to be Developed to Treat Early Stage Covid-19 Cases
January 26, 2021 08:30 ET
|
BetterLife Pharma
VANCOUVER, Jan. 26, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia
January 21, 2021 08:30 ET
|
BetterLife Pharma
VANCOUVER, Jan. 21, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and...
Global Multiple Sclerosis Therapies Report 2020-2025
December 08, 2020 08:53 ET
|
Research and Markets
Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
What do the Pfizer Vaccine and BetterLife Pharma have in common?
November 18, 2020 07:30 ET
|
BetterLife Pharma
New York City, Nov. 18, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotech company focused on development and...
BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Other Treatements
October 27, 2020 07:30 ET
|
BetterLife Pharma
New York City, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing for clinical...
Neurodegenerative Disorder Therapeutics Market, 2030 - Development of Novel therapies for Neurodegenerative Disorders through Gene and Cell Therapies
October 22, 2020 01:08 ET
|
Research and Markets
Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) -- The "Global Neurodegenerative Disorder Therapeutics Market: Focus on Product, Mechanism, Route of Administration, Indication, Country Data (14 Countries),...
BetterLife Announces VirTrial as Clinical Trial Patient Monitoring Partner
October 08, 2020 08:00 ET
|
BetterLife Pharma
VANCOUVER, Oct. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it...